Asthma Trial, Recruiting NCT06563544 Sponsor: Erasmus Medical Center Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06563544
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have agreed to take part and signed a consent form
  • You are currently on a breathing machine (ventilator) through a tube placed in your throat
  • The reason you needed the breathing tube was due to a severe flare-up of asthma or COPD
  • You have been on the breathing machine for 72 hours or less

Who may not be able to join:

  • You produce very large amounts of mucus that requires suctioning more than 5 times per nurse shift
  • You have a collapsed lung that has not yet been treated with a drain
  • Your blood pressure is dangerously low and is not improving with fluids or blood pressure medications, or you require very high doses of blood pressure medication
  • You have high or unstable pressure inside your skull that requires increasing levels of treatment to control
  • The breathing tube in your throat has a very narrow inner diameter (6mm or less)
  • Your care team is planning to move toward end-of-life or comfort-focused care
  • You are unable to have a special monitoring belt (called an EIT belt) fitted around your chest, for example due to: your chest size not fitting the belt, wounds, bandages or chest deformities, recent chest surgery within the last 7 days (including lung removal or transplant), having an implanted heart device (ICD), or having significant air trapped under the skin on your chest
  • You are unable to have a thin tube passed through your nose into your stomach, for example due to: recent surgery on your food pipe, previous removal of your food pipe, known swollen veins in your food pipe, or serious bleeding disorders

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Diederik P Gommers, Prof. Dr., Erasmus Medical Center

Phone: +31630600232

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Erasmus Medical Center
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 October 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

MV

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov